See also this year's filing and all EDGAR filings for this company.
PDF Report 0001107421_2023_Alaunos_Therapeutics_Inc.pdf
Logs
Graph
Absolute values for 0001107421, Alaunos Therapeutics Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 53,799,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 8,460,000 |
| 3 | remainder_Assets | 2,678,000 |
| 4 | LiabilitiesCurrent | 24,166,000 |
| 5 | LiabilitiesNoncurrent | 28,000 |
| 6 | remainder_Liabilities | 2,188,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 13,142,000 |
| 9 | ResearchAndDevelopmentExpense | 25,018,000 |
| 10 | remainder_Expenses | -133,000 |
| 11 | remainder_Revenues | 2,922,000 |
| 12 | remainder_NetIncome | -2,625,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 64,937,000 |
| 1 | Liabilities | 26,382,000 |
| 2 | Expenses | 38,027,000 |
| 3 | Revenues | 2,922,000 |
| 4 | StockholdersEquity | 38,555,000 |
| 5 | NetIncome | -37,730,000 |
| 6 | ComprehensiveNetIncome | -37,730,000 |
| 7 | BaseVar | 67,446,500 |
| 8 | EconomicCapitalRatio | 0.626 |
Edgar->Model Mapping
Feature Distribution
Change over Time
